FDA Mandates Safety Alterations to Opioid Pain Medication Labels
PharmExec
AUGUST 1, 2025
New labels will include study summaries, improved dosage warnings, and information on overdose reversal agents to enhance patient and healthcare professional awareness. The FDA mandates randomized clinical trials to assess long-term opioid use benefits and risks, ensuring timely and efficient completion.
Let's personalize your content